Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.40
Bid: 123.20
Ask: 124.00
Change: 1.60 (1.31%)
Spread: 0.80 (0.649%)
Open: 122.00
High: 125.40
Low: 122.00
Prev. Close: 121.80
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

C Share Conversion Ratio

13 Jan 2011 07:00

RNS Number : 3808Z
HSBC Infrastructure Company Limited
13 January 2011
 



 

13 January 2011

 

HSBC Infrastructure Company Limited

 

C Share Conversion Ratio and Admission of New Ordinary Shares to Official List and trading on the London Stock Exchange

 

 

Further to its announcement dated 10 January 2011, HSBC Infrastructure Company Limited ("HICL" or the "Company") is pleased to announce the following information in relation to the conversion of its C Shares.

 

 

Conversion Ratio for C Shares

The Net Asset Values attributable to the Ordinary Shares and the C Shares as at the Calculation Time, being 7 January 2011, were 111.1p per share and 98.3p per share respectively. The Conversion Ratio for conversion of the C Shares, as calculated in accordance with the Company's prospectus dated 17 November 2010 (the "Prospectus"), is 0.8850 Ordinary Shares for every one C Share held.

 

On the basis of the Conversion Ratio, a holder of 1,000 C Shares will receive 885 New Shares upon Conversion.

 

Entitlements will be rounded down to the nearest whole share. Any fractional entitlements will be aggregated and sold in the market for the benefit of the Company.

 

The Ordinary Shares arising on Conversion will rank pari passu with, and will have the same rights as, the Ordinary Shares of the Company already in issue.

 

Further details of the Conversion and rights attaching to the C Shares are set out in the Prospectus. Terms defined in the Prospectus have the same meaning in this announcement unless otherwise defined.

 

 

Admission to the Official List and to trading on the London Stock Exchange.

On the basis of the Conversion Ratio, application has been made to the UK Listing Authority for 97,350,000 New Shares to be admitted to the Official List. Application has also been made for the New Shares to be admitted to trading on the London Stock Exchange. It is expected that such admissions will become effective and that dealings in the New Shares will commence on 17 January 2011.

 

The C Shares will be permanently removed from trading on the London Stock Exchange with effect from the opening of trading at 8:00 a.m. on 17 January 2011.

 

 

Expected Timetable

The expected timetable for Conversion is as follows:

 

Record date for Conversion and C Share register closes

 

14 January 2011 (close of business)

Conversion Time and dealings in New Shares commence

 

17 January 2011

Crediting of CREST accounts with New Shares

 

17 January 2011

Share certificates in respect of New Shares despatched

 

Week commencing 17 January 2011

 

 

Voting Rights and Capital

Effective from 17 January 2011, the Company's share capital will consist of 595,139,454 Ordinary Shares with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

 

-ends-

For further information, please contact: 

HSBC Specialist Fund Management Limited

Tony Roper

Keith Pickard

Sandra Lowe

 

+44 (0) 20 7991 8888

Collins Stewart Europe Limited

David Yovichic

Dominic Waters

Robbie Robertson

 

+44 (0) 20 7523 8000

Oriel Securities Limited

Tom Durie

Emma Griffin

Gareth Price

 

+44 (0) 20 7710 7600

M: Communications

Ed Orlebar

Andrew Benbow

 

+44 (0) 20 7920 2330

 

The contents of this announcement have been prepared by and are the sole responsibility of HICL. Collins Stewart Europe Limited ("Collins Stewart") and Oriel Securities Limited ("Oriel Securities"), both of whom are regulated by the Financial Services Authority, are acting exclusively for HICL and no-one else and will not be responsible to anyone other than HICL for providing the protections afforded to the clients of Collins Stewart and Oriel Securities respectively, nor for affording advice in relation to the Issue, the contents of this announcement or any matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSDLVIFLIL
Date   Source Headline
17th Mar 202012:30 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSInterim Update Statement
26th Feb 20201:17 pmRNSThird Quarterly Interim Dividend
26th Feb 20207:00 amRNSNew Investment
31st Jan 20203:00 pmRNSTotal Voting Rights
16th Jan 20207:00 amRNSCapital Markets Seminar
9th Jan 20203:35 pmRNSIssue of Equity - Replacement
9th Jan 20203:05 pmRNSIssue of Equity
3rd Jan 202012:16 pmRNSHolding(s) in Company
2nd Jan 20204:30 pmRNSDirector/PDMR Shareholding
2nd Jan 20204:30 pmRNSDirector/PDMR Shareholding
2nd Jan 20207:00 amRNSTotal Voting Rights
18th Dec 20197:00 amRNSInvestment Manager
5th Dec 20197:00 amRNSAppointment of a New Director
3rd Dec 201912:48 pmRNSDirector/PDMR Shareholding
2nd Dec 20195:04 pmRNSDirector/PDMR Shareholding
29th Nov 20191:23 pmRNSResult of Placing
22nd Nov 20197:00 amRNSIssue of Equity
20th Nov 20197:01 amRNSPublication of Interim Report
20th Nov 20197:00 amRNSInterim Results Six Months Ended 30 September 2019
14th Nov 20194:30 pmRNSSecond Quarterly Interim Dividend
7th Nov 20197:00 amRNSDisposal of Two Investments
30th Oct 201911:02 amRNSNotice of Results
11th Oct 20197:00 amRNSNew Investments
9th Oct 20193:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20193:56 pmRNSDirector/PDMR Shareholding
24th Sep 20199:30 amRNSDirector Declaration
6th Aug 20197:00 amRNSInterim Update Statement
23rd Jul 201910:07 amRNSFirst Quarterly Interim Dividend
16th Jul 20194:52 pmRNSResult of AGM
5th Jul 20194:27 pmRNSDirector/PDMR Shareholding
5th Jul 20199:46 amRNSHolding(s) in Company
4th Jul 201911:51 amRNSDirector/PDMR Shareholding
25th Jun 20197:00 amRNSBroker Novation
17th Jun 20194:30 pmRNSDirector/PDMR Shareholding
11th Jun 20193:56 pmRNSHolding(s) in Company
11th Jun 201912:15 pmRNSNotice of AGM
11th Jun 201912:10 pmRNSAnnual Financial Report
29th May 20194:26 pmRNSFourth Quarterly Interim Dividend
22nd May 20197:00 amRNSAnnual Financial Report
1st May 20193:38 pmRNSNotice of Annual Results
1st Apr 20198:56 amRNSMove of Domicile and First Day of Dealings
28th Mar 20197:00 amRNSUpdate on New Investment
27th Mar 20195:51 pmRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSAppointment of New Director
26th Mar 201912:40 pmRNSResults of Extraordinary General Meeting
22nd Mar 20194:19 pmRNSTotal Voting Rights
22nd Mar 20191:00 pmRNSDirector/PDMR Shareholding
18th Mar 20197:00 amRNSNew Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.